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ABSTRACT  Microtubule (MT)-based transport of organelles driven by the opposing MT mo-
tors kinesins and dynein is tightly regulated in cells, but the underlying molecular mechanisms 
remain largely unknown. Here we tested the regulation of MT transport by the ubiquitous 
protein MAP4 using Xenopus melanophores as an experimental system. In these cells, pig-
ment granules (melanosomes) move along MTs to the cell center (aggregation) or to the pe-
riphery (dispersion) by means of cytoplasmic dynein and kinesin-2, respectively. We found 
that aggregation signals induced phosphorylation of threonine residues in the MT-binding 
domain of the Xenopus MAP4 (XMAP4), thus decreasing binding of this protein to MTs. Over-
expression of XMAP4 inhibited pigment aggregation by shortening dynein-dependent MT 
runs of melanosomes, whereas removal of XMAP4 from MTs reduced the length of kinesin-
2–dependent  runs  and  suppressed  pigment  dispersion.  We  hypothesize  that  binding  of 
XMAP4 to MTs negatively regulates dynein-dependent movement of melanosomes and pos-
itively regulates kinesin-2–based movement. Phosphorylation during pigment aggregation 
reduces binding of XMAP4 to MTs, thus increasing dynein-dependent and decreasing kinesin-
2–dependent motility of melanosomes, which stimulates their accumulation in the cell center, 
whereas dephosphorylation of XMAP4 during dispersion has an opposite effect.
INTRODUCTION
Intracellular  transport  is  essential  for  the  delivery  of  membrane-
bound organelles, RNA granules, and chromosomes to specific cel-
lular destinations and is critical for diverse biological processes such 
as mitosis, membrane trafficking, cell locomotion, and spatial orga-
nization  of  the  cytoplasm  (Lane  and  Allan,  1998;  Caviston  and 
Holzbaur,  2006;  Akhmanova  and  Hammer,  2010;  Walczak  et  al., 
2010; Kapitein and Hoogenraad, 2011; Stehbens and Wittmann, 
2012; Foley and Kapoor, 2013). Tracks for long-range intracellular 
transport are provided by cytoplasmic microtubules (MTs) organized 
into a polarized radial array with minus ends clustered in the cell 
center and plus ends pointing to the cell surface. The inherent polar-
ity of MTs is recognized by MT motors bound to the surface of cargo 
organelles and cytoplasmic particles. These motors—kinesins and 
dynein—use the energy of ATP hydrolysis to move cargoes specifi-
cally to the plus or minus ends of MTs (Vale, 2003). Kinesins gener-
ally  support  transport  to  the  MT  plus  ends  (Goldstein,  2001; 
Hirokawa et al., 2009; Verhey et al., 2011), whereas dynein is exclu-
sively minus-end directed (Hook and Vallee, 2006).
Opposing  MT  motors  are  usually  bound  to  the  surface  of 
the  same  cargo  organelles,  which  results  in  the  discontinuous 
(“saltatory”) pattern of their movement, with stochastic transitions 
among three states: uninterrupted displacements to the minus or 
plus ends, and pauses (Gross, 2004; Welte, 2004; Jolly and Gelfand, 
2011). The balance between the plus and minus end–directed runs, 
which determines the direction of MT transport, is tightly regulated 
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granules. To test this hypothesis and identify MAPs involved in the 
regulation of pigment granule transport, we compared phospho-
proteomic profiles of melanophores in the two signaling states.
We identified Xenopus MAP4 (XMAP4) as a protein whose phos-
phorylation levels significantly increased during pigment aggrega-
tion. We found that overexpression of XMAP4 did not affect disper-
sion of pigment granules but markedly reduced the rate of their 
aggregation, and this effect was explained by the shortening of MT 
minus-end runs. In a marked contrast to overexpression, removal of 
XMAP4 from MTs by microinjection of cells with a blocking antibody 
inhibited dispersion of pigment granules by shortening plus-end 
granule runs but did not affect their aggregation. Phosphomimetic 
mutant of XMAP4 had reduced abilities to bind MTs and inhibit ag-
gregation of pigment granules. On the basis of these results, we 
propose a model for the regulation of MT-based transport of pig-
ment  granules  in  melanophores  in  which  reversible  binding  of 
XMAP4 to MTs determines the direction of MT-based pigment gran-
ule movement.
RESULTS
XMAP4 is phosphorylated during pigment aggregation
To gain insight into the regulation of pigment transport in melano-
phores  and  understand  the  role  of  MAPs  in  this  regulation,  we 
compared  the  phosphoproteomic  profiles  of  cells  stimulated  to 
aggregate or disperse pigment granules. Phosphopeptides in un-
fractionated lysates of melanophores were enriched on iron immo-
bilized metal ion affinity chromatography or with TiO2 resin. We 
identified >5000 unique phosphopeptides whose abundance in-
creased in response to aggregation or dispersion signals. These 
peptides were derived from 2045 different proteins. Quantitative 
analysis of the phosphoproteomic data revealed 62 proteins whose 
phosphorylation levels changed in response to aggregation or dis-
persion stimuli more than fourfold. Among them were seven cy-
toskeleton-related proteins and only one structural MAP, XMAP4, 
whose phosphorylation increased during pigment aggregation. We 
cloned XMAP4 by PCR using cDNA synthesized from total RNA iso-
lated from Xenopus melanophores as a template and a pair of prim-
ers specific to the published nucleotide sequence of XMAP4 from 
Xenopus oocytes. The amino acid sequence of the melanophore-
specific XMAP4 was identical to the sequence of XMAP4 from oo-
cytes, except for a deletion of 57 amino acid residues at the C-ter-
minus and insertion of 10 amino acid residues in the middle of the 
molecule. We identified the amino acid residues phosphorylated 
during pigment aggregations as Thr-758 and Thr-762 located in the 
proline-rich region of the MT-binding domain (Figure 1). Phosphory-
lation of XMAP4 at Thr-758 and Thr-762 in melanophores stimulated 
to aggregate pigment increased more than fivefold compared with 
cells with dispersed pigment granules. Previous work showed that 
these threonines were targets of p34cdc2 and MAP kinases known to 
reduce the ability of mammalian MAP4 to bind MTs in HeLa cells 
(Ookata et al., 1995, 1997; Shiina and Tsukita, 1999; Kitazawa et al., 
2000; Chang et al., 2001). Taken together, these results indicate that 
XMAP4 is phosphorylated in melanophores in response to pigment 
aggregation signals and suggest that this phosphorylation reduces 
the affinity of XMAP4 to MTs.
Overexpression of XMAP4 slows aggregation of pigment 
granules
Phosphorylation  during  pigment  aggregation  suggested  that 
XMAP4  was  directly  or  indirectly  involved  in  the  regulation  of 
pigment granule transport. To understand the role of XMAP4 in 
transport of pigment granules, we examined the effect of XMAP4 
in cells. This regulation can involve changes in the numbers or the 
activation state of kinesin and dynein motors associated with car-
goes (Kamal and Goldstein, 2002; Karcher et al., 2002; Verhey and 
Hammond,  2009;  Akhmanova  and  Hammer,  2010;  Barlan  et  al., 
2013b)  or  modification  of  MT  transport  tracks  (Verhey  and 
Hammond, 2009). The state of MT tracks is influenced by specific 
posttranslational modifications of tubulin subunits (Liao and Gun-
dersen, 1998; Reed et al., 2006; Dunn et al., 2008; Cai et al., 2009; 
Konishi  and  Setou,  2009)  or  nonmotor  microtubule-associated 
proteins (MAPs).
MAPs are a group of proteins that bind along the length of MTs, 
promote  their  assembly,  and  stabilize  MTs  from  disassembly 
(Olmsted, 1986; Matus, 1988). Tau, microtubule-associated protein 
2 (MAP2), and MAP4 are structurally related MAPs that have similar 
MT-binding domains but different projection domains that extend 
from the MT surface. These MAPs act as obstacles for MT motors in 
general and kinesin motors in particular and negatively influence 
their motility by decreasing the frequency of attachment to MTs and 
the average length of MT runs (Atherton et al., 2013). In contrast to 
tau/MAP2/MAP4, doublecortin and MAP7/ensconsin stimulate in-
teraction of kinesin motors with MTs. Doublecortin and its homo-
logue, doublecortin-like kinase 1, selectively enhance the affinity of 
the kinesin-3 Kif1A to MTs (Liu et al., 2012), and MAP7/ensconsin 
increases the frequency of productive encounters of the kinesin-1 
motors with MTs (Sung et al., 2008; Metzger et al., 2012; Barlan et al., 
2013a). The ability of MAPs to enhance or inhibit motility of specific 
kinesin motors makes them likely targets for signaling cascades that 
regulate the direction of MT transport. The recruitment of MAPs to 
MTs is controlled by phosphorylation, which negatively affects their 
ability to bind MTs (Lee, 1993; Avila et al., 1994; Mandell and Banker, 
1996; Drewes et al., 1998; Cassimeris and Spittle, 2001). Therefore 
phosphorylation-dependent  changes  in  affinity  of  MAPs  to  MTs 
would be expected to affect the amount of plus end–directed motil-
ity of kinesin cargoes and thus the overall direction of MT-based 
transport.  However,  whether  MAPs  regulate  the  direction  of  MT 
transport in cells has not been directly tested.
In this study, we examined the regulation of MT transport by 
MAPs using Xenopus melanophores as an experimental system. In 
these  cells,  thousands  of  membrane-bound  pigment  granules 
move along radial MTs to the cell center (pigment aggregation) or 
the periphery (pigment dispersion) by means of cytoplasmic dy-
nein and kineisn-2, respectively (Nascimento et al., 2003; Kashina 
and Rodionov, 2005; Aspengren et al., 2009). Uniform distribution 
of pigment granules at later stages of dispersion involves move-
ment along randomly arranged actin filaments (Rodionov et al., 
1998; Rogers and Gelfand, 1998). The direction of transport is 
regulated by changes in the levels of a single second messenger 
cAMP, which alters the length of plus- and minus-end MT runs of 
pigment granules. An increase in cAMP levels induces an increase 
in the length of plus-end runs generated by kinesin-2 and a con-
current decrease in the length of minus-end runs produced by dy-
nein and leads to pigment dispersion (Gross et al., 2002; Rodionov 
et al., 2003; Zaliapin et al., 2005). A reduction in cAMP levels trig-
gers opposite changes in the length of granule runs and results in 
pigment aggregation (Gross et al., 2002; Rodionov et al., 2003; 
Zaliapin et al., 2005). cAMP levels affect the activity of protein ki-
nase A (PKA) and other protein kinases that act downstream of 
PKA in the signaling cascades that regulate the motility of pigment 
granules (Rodionov et al., 2003; Deacon et al., 2005; Ikeda et al., 
2011). We hypothesized that if MAPs regulate pigment granule 
transport, their phosphorylation levels should change in response 
to  signals  that  trigger  aggregation  or  dispersion  of  pigment Volume 25  October 15, 2014  Regulation of transport by MAP4  |  3121 
tively, as compared with control nontransfected or EGFP-expressing 
cells (Figure 2B). However, 1 h after application of pigment aggrega-
tion stimuli, the fractions of cells with aggregated or partially re-
sponded pigment granules approached control levels (Figure 2C), 
indicating that overexpression of EGFP-XMAP4 did not block pig-
ment aggregation completely but instead slowed accumulation of 
pigment granules in the cell center. We conclude that overexpres-
sion of EGFP-XMAP4 significantly reduces the rate of pigment gran-
ule aggregation.
Inhibition of pigment granule aggregation in cells 
overexpressing EGFP-XMAP4 is not explained by reduced 
rate of transfer of pigment granules from actin filaments 
onto MTs
Our data showed that overexpression of EGFP-XMAP4 dramatically 
delayed aggregation of pigment granules. Pigment aggregation in-
cludes two independent steps—the transfer of pigment granules 
from actin filaments onto MTs, and subsequent transport along MTs 
to the cell center. Either step could be inhibited by the overexpres-
sion of EGFP-XMAP4. Our previous work showed that the transfer 
step involves capture of pigment granules by growing MT tips and 
that the +TIP protein CLIP170 is essential for this process (Lomakin 
et al., 2009, 2011). It was therefore possible that EGFP-XMAP4 in-
hibited pigment granule capture by suppressing MT dynamics or 
preventing accumulation of CLIP-170 at the MT plus ends. In sup-
port of this possibility, overexpression of MAP4 in mammalian cells 
stabilized cytoplasmic MTs (Nguyen et al., 1997; Holmfeldt et al., 
2002), and MAP1b, a MAP structurally related to MAP4, reduced the 
levels of MT-associated EB1, an adaptor protein that facilitates bind-
ing of CLIP-170 to MT tips (Tortosa et al., 2013). We therefore sought 
to  determine  whether  overexpression  of  EGFP-XMAP4  inhibited 
pigment granule aggregation by suppressing MT dynamics or re-
ducing binding of CLIP-170 to the plus ends of MTs.
To examine the effect of EGFP-XMAP4 overexpression on MT 
dynamics, we compared parameters of MT dynamic instability in 
melanophores  induced  to  aggregate  pigment  granules  overex-
pressing  EGFP-XMAP4  and  EGFP  by  injecting  Cy3-tubulin  into 
overexpression on pigment aggregation and dispersion. XMAP4 
was expressed in melanophores as an enhanced green fluorescent 
protein (EGFP) fusion to identify the overexpressing cells. Fluores-
cence microscopy indicated that, as expected, EGFP-XMAP4 bound 
cytoplasmic MTs (Supplemental Figure S1). To measure the effects 
of EGFP-XMAP4 overexpression on pigment granule transport, we 
stimulated pigment aggregation or dispersion and quantified the 
fractions of cells with aggregated, partially responded, or dispersed 
pigment granules 15 min after stimulation. Nontransfected melano-
phores or cells expressing EGFP were used as controls. We found 
that overexpression of EGFP-XMAP4 did not affect significantly pig-
ment granule dispersion (Figure 2A) but dramatically inhibited their 
aggregation, as evidenced from the approximately eightfold and 
approximately twofold increases in the fractions of cells whose pig-
ment granules remained completely and partially dispersed, respec-
FIGURE 1:  XMAP4 is phosphorylated at threonine residues located in 
the proline-rich region of the MT-binding domain. Top, amino acid 
sequence of the XMAP4 phosphopeptide identified in the 
phosphoproteomic screen; Thr-758 and Thr-762 are shown in red; 
bottom, domain organization of the XMAP4 molecule; the molecule 
of XMAP4 is composed of an N-terminal projection domain, which 
protrudes from the MT surface, and a C-terminal MT-binding domain 
that contains a proline-rich region and four imperfect amino acid 
repeats (Aizawa et al., 1991; Chapin and Bulinski, 1991); Thr-758 and 
Thr-762 map to the proline-rich region of the MT-binding domain.
FIGURE 2:  Expression of XMAP4 reduces the rate of pigment aggregation. Quantification of response to dispersion 
(A) or aggregation (B, C) stimuli applied for 15 min (A, B) or 1 h (C) to melanophores expressing EGFP-XMAP4 (left set 
of bars), EGFP (middle sets of bars in A and B, right set in C), or nontransfected melanophores (right sets of bars in A 
and B); data are expressed as the percentages of cells with aggregated (white bars), partially responded (gray bars), or 
dispersed (black bars) pigment granules. Expression of EGFP-XMAP4 does not affect dispersion but significantly slows 
aggregation of pigment granules, as evidenced by the increase in the fractions of cells with dispersed or partially 
responded pigment granules 15 min after the stimulation of pigment aggregation.3122  |  I. Semenova et al.  Molecular Biology of the Cell
changes in MT dynamics could not explain the dramatic inhibition of 
pigment aggregation observed in the EGFP-XMAP4–overexpress-
ing cells.
To determine whether EGFP-XMAP4 displaced CLIP-170 from 
MT plus ends, we immunostained melanophores overexpressing 
EGFP  or  EGFP-XMAP4  with  a  CLIP-170  antibody  and  used 
images of the immunostained cells to generate normalized pro-
files of the CLIP-170 fluorescence at MT plus ends (Figure 3B). 
Quantitative analysis of the fluorescence profiles showed that 
the average length of MT segments decorated with CLIP-170 
was similar between the EGFP- and EGFP-XMAP4–overexpress-
ing melanophores (0.67 ± 0.05 and 0.68 ± 0.06 μm, respectively). 
Absolute values of CLIP-170 fluorescence per MT end were also 
similar  between  melanophores  expressing  EGFP  and  EGFP-
XMAP4 (331 ± 13 and 428 ± 15 arbitrary units, respectively). 
Thus overexpression of EGFP-XMAP4 did not remove CLIP-170 
from the MT plus ends. Taken together, the results of these ex-
periments  indicate  that  inhibition  of  pigment  aggregation  in 
melanophores overexpressing EGFP-XMAP4 is not explained by 
the reduced transfer of pigment granules from actin filaments 
onto MTs during pigment aggregation.
Overexpression of EGFP-XMAP4 reduces the length of 
minus-end MT runs of pigment granules during pigment 
aggregation
Our data indicated that overexpression of EGFP-XMAP4 did not af-
fect capture of pigment granules by growing MT tips during pig-
ment aggregation. During pigment aggregation, granules captured 
by MTs run to the MT minus ends focused in the cell center. We 
therefore tested whether overexpression of EGFP-XMAP4 affected 
minus end–directed granule motility by tracking individual pigment 
granules and decomposing motion trajectories into plus- and mi-
nus-end runs and pauses. For pigment granule tracking, we used 
melanophores expressing EGFP-XMAP4 at low levels, which aggre-
gated pigment granules at a slightly reduced rate. This partial inhibi-
tion of pigment aggregation allowed us to estimate parameters of 
bidirectional  granule  movement.  Control  experiments  involved 
tracking of pigment granules in melanophores expressing EGFP. 
EGFP-positive cells, tracking tips of growing and shortening MTs, 
and decomposing tip trajectories into periods of growth, shorten-
ing, and pauses. We detected small but significant differences in the 
parameters of MT dynamic instability between the EGFP-XMAP4- 
and  EGFP-expressing  cells  (Table  1).  In  particular,  the  average 
lengths of growth and shortening episodes were slightly reduced 
and the average duration of pauses increased in the melanophores 
overexpressing EGFP-XMAP4 (Table 1). To determine whether these 
changes affected the rate of pigment granule aggregation, we used 
a stochastic computational model for pigment aggregation that we 
previously developed (Lomakin et al., 2009, 2011). The model com-
putes kinetics of pigment granule aggregation based on the statis-
tics of bidirectional movement of pigment granules, the probability 
of pigment granule capture by growing MT ends, and parameters of 
MT dynamic instability and allows one to estimate independent ef-
fects of changes in MT dynamics on the pigment aggregation rate 
(Zaliapin et al., 2005; Lomakin et al., 2009, 2011). The output of the 
model is the kinetics of gray level decrease, which reflects how fast 
the cytoplasm becomes increasingly transparent as pigment gran-
ules accumulate in the cell center. We first tested the model by per-
forming experimental measurements of gray level decrease in cells 
expressing EGFP and comparing experimental data with the results 
of simulations that used the parameters of MT dynamic instability 
and pigment granule movement measured in these cells (Tables 1 
and 2). This comparison showed a close match between the experi-
mental  and  computed  kinetic  curves  (Supplemental  Figure  S2). 
These  results,  in  agreement  with  our  previous  analyses  (Zaliapin 
et al., 2005; Lomakin et al., 2009, 2011), demonstrated that the 
computational model closely reproduced the kinetics of pigment 
aggregation. We next simulated aggregation of pigment granules 
using parameters of MT dynamic instability measured in melano-
phores overexpressing EGFP-XMAP4 (Table 1) without changing the 
granule  movement  statistics.  These  computer  simulations  gener-
ated kinetics of gray level decrease (Figure 3A, open squares) that 
was close to the kinetics measured for the EGFP-expressing cells 
(Figure 3A, open circles), with a half-time 4.36 ± 0.19 min. The ex-
perimentally measured half-time of gray level decrease estimated 
for melanophores overexpressing EGFP-XMAP4 (Figure 3A, black 
squares) was 27.78 ± 4.77 min, much longer than the half-time com-







Growth length (μm) 1.06 ± 0.09* 1.41 ± 0.10*
Growth rate (μm/s) 0.09 ± 0.01 0.11 ± 0.01
Shortening length (μm) 0.73 ± 0.09* 1.27 ± 0.11*
Shortening rate (μm/s) 0.09 ± 0.01* 0.13 ± 0.01*
Catastrophe frequency (s−1) 0.048 ± 0.001* 0.041 ± 0.001*
Rescue frequency (s−1) 0.053 ± 0.001* 0.047 ± 0.001*
Pause duration (s) 5.19 ± 0.31* 3.96 ± 0.22*
Number of analyzed MTs 40 41
Number of analyzed cells 20 14
Values are marked with an asterisk if the difference of the mean parameter 
value between EGFP-XMAP4– and EGFP-expressing cells is significant at the 
0.05 level, according to a one-way analysis of variance test.
TABLE 1:  Parameters of MT dynamic instability in melanophores with 






Velocity of minus-end 
runs (nm/s)
401.5 ± 7.5 386.6 ± 8.5
Length of minus-end 
runs (nm)
117.1 ± 4.5* 161.9 ± 8.6*
Velocity of plus-end 
runs (nm/s)
355.5 ± 9.2 337.9 ± 10.1
Length of plus-end 
runs (nm)
36.8 ± 0.7* 39.5 ± 1.2*
Duration of pauses (s) 0.69 ± 0.03 0.66 ± 0.03
Number of analyzed 
pigment granules
121 80
Values are marked with an asterisk if the difference of the mean parameter 
value between EGFP-XMAP4– and EGFP-expressing cells is significant at the 
0.05 level, according to a one-way analysis of variance test.
TABLE 2:  Parameters of MT-based movement of pigment granules 
during pigment aggregation in melanophores expressing EGFP-
XMAP4 or EGFP.Volume 25  October 15, 2014  Regulation of transport by MAP4  |  3123 
antibodies (Figure 4A) likely represented degradation products of 
XMAP4, since the corresponding proteins cosedimented with MTs 
assembled in cell extracts (unpublished data). In extracts of melano-
phores overexpressing EGFP-XMAP4, MBD antibodies recognized 
an additional band with electrophoretic mobility characteristic of the 
EGFP-XMAP4 (Figure 4A, right). The apparent molecular weights of 
the immunoreactive proteins were higher than the values predicted 
for the XMAP4 or GFP-XMAP4 based on the amino acid sequence. 
However, previous studies showed that the mobility of mammalian 
MAP4 on SDS gels was also unusually slow (Aizawa et al., 1990; 
West et al., 1991; Chapin et al., 1995). Therefore immunoblotting 
experiments  showed  that  MBD  antibodies  were  specific  for  the 
XMAP4.
To  test  whether  antibodies  against  MBD  blocked  binding  of 
XMAP4 to MTs in vitro, we assembled MTs in cell extracts in the 
presence  or  absence  of  control  nonimmune  immunoglobulin  G 
(IgG) or MBD antibodies, pelleted MTs through a glycerol cushion to 
separate soluble and MT-bound MAPs, and examined the composi-
tion of MAPs in the MT pellets. MTs assembled in cell extracts bound 
numerous MAPs (Figure 4B, left), and preincubation of extracts with 
nonimmune IgG did not change composition of MAPs in the MT 
pellets. However, preincubation with MBD antibodies removed from 
MT pellets a single band with electrophoretic mobility characteristic 
of XMAP4 (Figure 4B, right). Western blots confirmed that XMAP4 
was absent from the pellets of MTs assembled in the presence MBD 
antibodies but not control nonimmune IgG (Supplemental Figure 
S3). Therefore MBD antibodies completely and selectively blocked 
the binding of XMAP4 to MTs in vitro.
To determine whether MBD antibodies removed XMAP4 from 
MTs in cells, we transfected melanophores with EGFP-XMAP4 and 
microinjected EGFP-positive cells with MBD antibodies or control 
nonimmune IgG. We found that, as expected, EGFP-XMAP4 was 
bound along the length MTs (Figure 4C, left) and that microinjection 
of antibodies against MBD caused rapid (20 min) and complete loss 
of MT fluorescence and redistribution of the EGFP signal into bright 
spots randomly distributed throughout the cytoplasm (Figure 4C, 
Comparison of pigment granule movement parameters between 
the EGFP- and EGFP-XMAP4–expressing cells showed that EGFP-
XMAP4 expression did not change the average velocity or length of 
plus-end  granule  runs  (Table  2).  However,  expression  of  EGFP-
XMAP4 reduced the average length of minus-end runs to 72% of 
the control levels, without affecting their velocity (Table 2). For com-
parison with pigment aggregation, we also performed tracking of 
pigment  granules  in  melanophores  expressing  EGFP-XMAP4  or 
GFP shortly after the stimulation of pigment granule dispersion. Our 
previous work indicates that at early stages of pigment dispersion, 
granules move exclusively along the radial MT tracks (Zaliapin et al., 
2005; Slepchenko et al., 2007). We did not find any significant differ-
ences in minus-end run length or other granule movement statistics 
between  populations  of  melanophores  expressing  EGFP-XMAP4 
and EGFP (Supplemental Table S1). We conclude that expression of 
EGFP-XMAP4 does not significantly affect parameters of pigment 
granule movement during their dispersion and inhibits pigment ag-
gregation by reducing the length of minus-end runs of pigment 
granules.
Removal of XMAP4 from MTs selectively inhibits dispersion 
of pigment granules
To further understand the role of XMAP4 in pigment transport, we 
next tested whether removal of XMAP4 from MTs affected aggrega-
tion or dispersion of pigment granules. To remove XMAP4 from 
MTs, we produced antibodies against the XMAP4 microtubule-bind-
ing domain (MBD). Such antibodies have been shown to block bind-
ing of mammalian MAP4 to MTs in vivo and in vitro (Wang et al., 
1996). We performed several control experiments to confirm that 
our antibodies against XMAP4 MBD were specific and had the pre-
dicted blocking effect.
To examine whether MBD antibodies were specific for XMAP4, 
we performed immunoblotting with whole-cell extracts. In extracts 
of control, nontransfected melanophores the antibodies recognized 
a major band with apparent molecular weight ∼250 kDa (Figure 4A, 
left). The additional lower–molecular weight bands bound to MBD 
FIGURE 3:  Inhibition of pigment aggregation in melanophores overexpressing XMAP4 cannot be explained by changes 
in MT dynamics or loss of CLIP-170 from the MT tips. (A) Comparison of kinetics of pigment aggregation measured in 
cells expressing EGFP-XMAP4 (black squares) or computed based on parameters of MT dynamic instability measured in 
EGFP-expressing (white circles) or EGFP-XMAP4–expressing cells (white squares); changes in parameters of MT 
dynamic instability caused by the overexpression of EGFP-XMAP4 cannot account for inhibition of pigment aggregation 
in the EGFP-XMAP4–expressing cells. (B) Profiles of CLIP-170 fluorescence at MT plus ends normalized by maximum 
fluorescence and averaged for melanophores expressing EGFP (black squares) or EGFP-XMAP4 (white circles); 
expression of EGFP-XMAP4 does not significantly change the distribution of the CLIP-170 fluorescence at the MT 
plus ends.3124  |  I. Semenova et al.  Molecular Biology of the Cell
right). These spots likely represented EGFP-
XMAP4–MBD  antibody  complexes.  Micro-
injection of control nonimmune IgG did not 
affect MT localization of EGFP-XMAP4 (un-
published  data),  which  indicated  that  the 
blocking effect of the MBD antibodies was 
highly  specific.  Immunofluorescence  stain-
ing with anti-tubulin antibody showed that 
the  MT  network  appeared  normal  in  the 
MBD antibody–injected cells (Supplemental 
Figure S4). Furthermore, antibody microin-
jection did not significantly affect parame-
ters of MT dynamic instability. The lengths 
of  growth  and  shortening  episodes  were 
slightly  reduced  in  antibody-injected  cells 
compared with melanophores injected with 
nonimmune  IgG  (Supplemental  Table  S2). 
However,  growth  and  shortening  of  MTs 
were affected to about the same extent, and 
therefore  these  changes  in  MT  dynamics 
could not cause significant reduction in MT 
density. These results are in line with pub-
lished  data  that  showed  that  depleting 
MAP4 from MTs had no detectable effect on 
the distribution or dynamics of MTs in hu-
man fibroblasts and monkey kidney epithe-
lial cells (Wang et al., 1996). Therefore mi-
croinjection of antibodies against MBD into 
melanophores abolished binding of XMAP4 
to MTs without changing MT organization or 
dynamics.
We  next  tested  whether  removal  of 
XMAP4 from MTs affected pigment gran-
ule transport. We injected melanophores 
with MBD antibodies or nonimmune IgG, 
stimulated pigment aggregation or disper-
sion, and estimated the fractions of cells 
with  aggregated,  partially  responded,  or 
dispersed  pigment  granules.  Microinjec-
tion of antibodies against MBD significantly 
inhibited pigment dispersion, as evidenced 
by the approximately ninefold increase in 
the fraction of cells whose response to dis-
persion  signal  was  completely  inhibited 
and a twofold increase in the fraction of 
cells  that  showed  partial  inhibition  com-
pared  with  melanophores  microinjected 
FIGURE 4:  Displacement of XMAP4 from MTs by injection of MBD antibodies inhibits dispersion 
but not aggregation of pigment granules. (A) Immunoblotting with MBD antibodies of whole-
cell extracts of control nontransfected cells (left) or melanophores overexpressing EGFP-XMAP4 
(right); MBD antibodies recognize the XMAP4 band in whole-cell extracts of control cells and an 
additional EGFP-XMAP4 band in whole-cell extracts of EGFP-XMAP4–overexpressing cells. 
(B) Coomassie-stained SDS gels of pelleted MTs assembled in whole-cell extracts preincubated 
without added IgG (left), in the presence of control nonimmune IgG (middle), or antibodies 
against XMAP4 MBD (right); preincubation of whole-cell extracts with MBD antibodies prevents 
cosedimentation of XMAP4 but not other MAPs with MTs. (C) Live images of a melanophore 
expressing EGFP-XMAP4 before (left) and 30 min after (right) injection of antibodies against 
XMAP4 MBD; scale bar, 20 μm; the antibody 
injection completely removes XMAP4 from 
the MTs. (D) Quantification of response to 
dispersion (left) or aggregation (right) stimuli 
of melanophores microinjected with 
nonimmune IgG or antibodies against 
XMAP4 MBD. Microinjection of MBD 
antibodies does not significantly affect 
pigment aggregation but markedly inhibits 
pigment dispersion, as evidenced by 
increases in the fractions of cells with 
aggregated or partially responded pigment 
granules compared with melanophores 
microinjected with nonimmune IgG.Volume 25  October 15, 2014  Regulation of transport by MAP4  |  3125 
XMAP4 interacts with the p150Glued subunit of the dynactin 
complex but does not bind subunits of MT motor proteins
Our data showed that overexpression of EGFP-XMAP4 dramatically 
reduced the rate of pigment aggregation by shortening the length 
of minus-end runs of pigment granules, whereas removal of EGFP-
XMAP4 from MTs suppressed pigment dispersion mainly by reduc-
ing the length of plus-end granule runs. Given that minus-end runs 
of pigment granules are generated by dynein (Nilsson and Wallin, 
1997) and plus-end runs by kinesin-2 (Tuma et al., 1998), these re-
sults indicated that XMAP4 bound to MTs negatively regulated dy-
nein motility and positively regulated motility of kinesin-2. MAPs are 
known to block travel of motor proteins, including dynein (Lopez 
and Sheetz, 1993; Vershinin et al., 2007, 2008; Dixit et al., 2008; 
Markus et al., 2012), along MTs, and therefore the negative effect of 
XMAP4  overexpression  on  dynein  motility  is  likely  explained  by 
steric interference with the movement of dynein motors by EGFP-
XMAP4 molecules bound to the MT surface. However, tethering of 
dynein to MTs mediated by XMAP4 could enhance an inhibitory ef-
fect. On the contrary, positive regulation of kinesin-2 suggests direct 
or indirect interaction of this motor protein with XMAP4. In support 
of a role for MAP–motor interaction in stimulation of kinesin motility, 
docking the motor domain of kinesin-3 Kif1A to MTs by doublecor-
tin was shown to enhance transport of Kif1A cargoes in neurons (Liu 
et al., 2012). Therefore, to further understand the mechanisms of 
regulation of MT motor proteins by XMAP4, we sought to deter-
mine whether XMAP4 interacts with kinesin-2 or dynein or the dy-
nactin complex that mediates their binding to pigment granules.
To investigate whether XMAP4 interacts with MT motor proteins 
or  the  dynactin  complex,  we  immunoprecipitated  XMAP4  from 
whole-cell extracts and probed immunoprecipitates with antibodies 
specific for kinesin-2, dynein, or dynactin subunits. To avoid compe-
tition of XMAP4 binding partners with antibodies during immuno-
precipitation,  we  expressed  EGFP-XMAP4  in  melanophores  and 
used rabbit antibodies specific for the EGFP tag for immunoprecipi-
tation. To confirm the presence of EGFP-XMAP4 in the immunopre-
cipitates, we probed them with mouse monoclonal EGFP antibod-
ies. We found that, as expected, immunoprecipitates contained a 
protein band with electrophoretic mobility consistent with the mo-
bility of EGFP-XMAP4 (Figure 5A). We also found, however, that 
antibodies against Kif3A subunit of kinesin-2 or cytoplasmic dynein 
IC, which recognized relevant bands in whole-cell extracts, did not 
react with immunoprecipitates (Figure 5A), suggesting that neither 
kinesin-2 nor dynein bound XMAP4 with high affinity in whole-cell 
extracts. In contrast to antibodies specific for MT motor proteins, 
antibody raised against the 150Glued subunit of the dynactin com-
plex  revealed  in  immunoprecipitates  a  protein  with  appropriate 
electrophoretic mobility (Figure 5A). To examine whether endoge-
nous MAP4 also bound p150Glued and to exclude the possibility that 
the presence of p150Glued in EGFP antibody immunoprecipitates 
could be explained by nonspecific binding of p150Glued to EGFP, we 
pulled down XMAP4 from extracts of nontransfected cells using the 
XMAP4 MBD antibodies. Once again, we detected the p150Glued 
band  in  the  immunoprecipitate  obtained  with  MBD  antibodies 
(Figure 5B). We conclude that XMAP4 binds the p150Glued subunit of 
the dynactin complex but not subunits of MT motor proteins.
Phosphorylation decreases affinity of XMAP4 for MTs and 
reduces inhibition of pigment granule aggregation
Our phosphoproteomic profiling indicated that aggregation signals 
significantly increased phosphorylation of Thr-758 and Thr-763 lo-
cated in the MT-binding domain of the XMAP4 molecule (Figure 1). 
It is known that phosphorylation of the MT-binding domain inhibits 
with nonimmune IgG (Figure 4D, left). Aggregation of pigment 
granules was not significantly affected, given that the fractions of 
cells with completely or partially aggregated pigment granules 
were similar between populations of melanophores microinjected 
with MBD antibodies or nonimmune IgG (Figure 4D, right). Fur-
thermore, microinjection of MBD antibodies did not significantly 
change  parameters  of  bidirectional  granule  movement  during 
pigment aggregation (Supplemental Table S3). Thus removal of 
XMAP4  from  MTs  selectively  inhibited  dispersion  of  pigment 
granules.
Dispersion  of  pigment  granules  in  XMAP4  antibody–injected 
cells could be inhibited through decrease in the length or velocity of 
plus-end granule runs, increase in the length or velocity of minus-
end runs, or both. To determine how depletion of XMAP4 from MTs 
affected parameters of bidirectional granule movement, we micro-
injected cells with MBD antibodies or control nonimmune IgG and 
recorded and tracked individual pigment granules shortly after the 
application of a pigment dispersion stimulus. To allow for the track-
ing of pigment granules, we decreased the amounts of MBD anti-
bodies and nonimmune IgG delivered into the cytoplasm during 
microinjection by reducing microinjection time by ∼50%. Reduced 
cytoplasmic levels of MBD antibodies slowed pigment dispersion 
but did not block it completely, as evidenced by the increased frac-
tion of cells with partially dispersed pigment granules compared 
with melanophores injected with control nonimmune IgG (Supple-
mental Figure S5). Partial inhibition of pigment granule dispersion 
made possible measurements of the velocity and length of bidirec-
tional granule runs. Comparison of granule movement statistics be-
tween  cells  microinjected  with  MBD  antibodies  and  control  IgG 
showed that MBD antibodies reduced pigment granule runs in both 
directions and that the average length of runs was affected more 
significantly than run velocity, reaching ∼70% of the control values 
(Table 3). Further, the average length of plus- and minus-end runs 
was reduced to about the same extent, but the net effect was more 
prominent in the case of longer plus-end runs, which shortened 
by ∼30 nm (Table 3). We conclude that XMAP4 positively regulates 
motility of pigment granules along MTs in both directions and stim-








Velocity of minus-end 
runs (nm/s)
250.3 ± 9.9 272.0 ± 10.1
Length of minus-end 
runs (nm)
53.8 ± 1.5* 74.4 ± 4.1*
Velocity of plus-end 
runs (nm)
250.7 ± 7.5 271.2 ± 7.6
Length of plus-end 
runs (nm)
111.3 ± 4.1* 141.5 ± 5.5*
Duration of pauses (s) 1.1 ± 0.1 1.1 ± 0.1
Number of analyzed 
pigment granules
98 116
Values are marked with an asterisk if the difference of the mean parameter 
value between XMAP4 antibody and IgG-injected cells is significant at the 
0.05 level, according to a one-way analysis of variance test.
TABLE 3:  Parameters of MT-based movement of pigment granules 
during pigment dispersion in melanophores microinjected with 
antibody against XMAP4 MT-binding domain or control IgG.3126  |  I. Semenova et al.  Molecular Biology of the Cell
tagged  phosphomimetic  and  nonphosphorylatable  mutants  in 
baculovirus, purified recombinant proteins by chromatography on 
Ni-nitrilotriacetic acid (NTA) agarose (Supplemental Figure S7), and 
compared their ability to cosediment with MTs in vitro.
For  the  MT  cosedimentation,  we  combined  purified  XMAP4 
phosphomimetic or nonphosphorylatable mutant proteins with pa-
clitaxel-stabilized MTs to attain a final concentration equimolar to 
tubulin and pelleted MTs by high-speed centrifugation. We found 
that the Thr-758E/Thr-756E band was reduced in the MT pellets and 
increased in the supernatants compared with the Thr-758A/Thr-756A 
band (Figure 6B, top). Measurement the amounts of XMAP4 mutant 
proteins in the MT pellets using quantitative immunoblotting con-
firmed that intensity of the Thr-758E/Thr-756E band was on average 
∼1.4-fold lower than that of the Thr-758A/Thr-756A band (Figure 6B). 
Therefore binding to MTs of the phosphomimetic mutant protein 
compared with the nonphosphorylatable mutant protein was signifi-
cantly decreased. We conclude that phosphorylation at Thr-758 and 
Thr-756 reduces binding of XMAP4 to MTs and partially relieves inhi-
bition of pigment aggregation in the overexpressing cells.
Our phosphoproteomic profiling indicated that phosphorylation 
of XMAP4 is increased during pigment granule aggregation, and 
the results of MT cosedimentation experiments showed that this 
phosphorylation reduced binding of XMAP4 to MTs. Therefore the 
levels of endogenous MT-bound XMAP4 should decrease during 
pigment aggregation. We therefore compared the levels of MT-
bound XMAP4 in melanophores stimulated to aggregate or dis-
perse pigment granules by measuring XMAP4 fluorescence after 
immunostaining with antibodies against XMAP4 MBD. To reduce 
background fluorescence, we extracted cells with 0.5% Triton X-100 
before fixation. We found that the endogenous XMAP4 was associ-
ated with MTs in both signaling states. However, XMAP4 MT fluores-
cence in cells stimulated to disperse pigment granules appeared 
brighter than in melanophores induced to disperse pigment gran-
ules (Supplemental Figure S8). Averaging measurements of XMAP4 
MT fluorescence in 20 cells in each signaling state confirmed that 
the brightness of MTs was higher in cells treated to disperse than 
aggregate pigment granules (60.9 ± 1.39 vs. 45.6 ± 1.44 arbitrary 
units, respectively; mean ± SEM; n = 100). This result was highly 
statistically significant (p = 1.4 × 10−12). We conclude that pigment 
aggregation signals that induce XMAP4 phosphorylation partially 
remove XMAP4 from MTs.
DISCUSSION
In this study, we identified XMAP4 as an important regulator of MT-
based transport of pigment granules in Xenopus melanophores. 
This conclusion is based on several lines of experimental evidence. 
First, overexpression of XMAP4 significantly slowed pigment aggre-
gation, without affecting pigment dispersion. This effect could be 
explained by a reduced length of minus-end MT runs of pigment 
granules in overexpressing cells. Second, removal of XMAP4 from 
MTs did not influence pigment aggregation but suppressed pig-
ment dispersion by reducing the length of plus-end granule runs. 
Finally, binding of XMAP4 to MTs and the inhibition of pigment 
granule aggregation by overexpression of XMAP4 were reduced by 
using phosphomimetic mutations. Therefore our work for the first 
time demonstrates that phosphorylation-dependent changes in the 
binding of a structural MAP to MTs regulate the direction of MT 
transport of membrane organelles.
Our data show that overexpression of XMAP4 reduces the aver-
age length of minus-end MT runs of pigment granules generated by 
dynein. This result is in line with the results of other studies that indi-
cate that MAP4 inhibits dynein motility. Overexpression of MAP4 in 
binding of mammalian MAP4 to MTs (Illenberger et al., 1996; Ki-
tazawa et al., 2000; Chang et al., 2001). Furthermore, threonine resi-
dues in the mammalian MAP4 that correspond to the XMAP4 Thr-
758 and Thr-762 are phosphorylated by p34cdc2 and MAP protein 
kinases during the transition from interphase to mitosis, and this 
phosphorylation correlates with a decrease in the ability of MAP4 to 
bind cytoplasmic MTs (Ookata et al., 1995, 1997; Shiina and Tsukita, 
1999). We hypothesized that phosphorylation of XMAP4 at Thr-758 
and Thr-762 reduces the binding of XMAP4 to MTs, removing physi-
cal barriers in the path of dynein motors moving pigment granules 
to the cell center, thus accelerating pigment aggregation.
To determine whether phosphorylation of XMAP4 at Thr-758 and 
Thr-762 affects aggregation of pigment granules, we compared the 
response  to  aggregation  signal  of  melanophores  overexpressing 
the EGFP-tagged Thr-758E/Thr-756E phosphomimetic or Thr-758A/
Thr-762A nonphosphorylatable XMAP4 mutants. Measurement of 
pigment aggregation responses showed that the phosphomimetic 
XMAP4 mutant had a reduced inhibitory effect on pigment aggre-
gation  compared  with  the  nonphosphorylatable  mutant,  as  evi-
denced by the statistically significant (p = 0.03) increase in the frac-
tion of cells with aggregated pigment granules from 29 to 41%, 
concomitant with a decrease in the fraction of melanophores with 
dispersed pigment (Figure 6A). This effect could not be explained 
by a difference in the expression levels of mutant proteins (Figure 
6B). As expected, overexpression of phosphomimetic or nonphos-
phorylatable XMAP4 mutants did not significantly affect pigment 
dispersion (Supplemental Figure S6). Therefore phosphorylation at 
Thr-758 and Thr-756 reduced the inhibitory effect of XMAP4 on pig-
ment aggregation.
To test whether phosphorylation at Thr-758 and Thr-756 affected 
binding  of  XMAP4  to  MTs,  we  expressed  hexahistidine  (6xHis)-
FIGURE 5:  XMAP4 binds dynactin but not MT motor proteins. 
(A) Whole-cell extracts or immunoprecipitates of EGFP-XMAP4 with 
rabbit polyclonal antibodies against EGFP probed with mouse 
monoclonal antibodies specific for EGFP (EGFP), Kif3A subunit of 
kinesin-2 (Kif3A), dynein IC (DIC), or the p150Glued subunit of the 
dynactin complex (p150Glued); p150Glued but not kinesin-2 or dynein 
coimmunoprecipitates with EGFP-XMAP4. (B) Immunoprecipitate of 
the endogenous XMAP4 with antibodies against XMAP4 MBD probed 
with an antibody against p150Glued; p150Glued coimmunoprecipitates 
with endogenous XMAP4. E, whole-cell extract; IP, immuno-
precipitate.Volume 25  October 15, 2014  Regulation of transport by MAP4  |  3127 
minus end–directed MT movement of pig-
ment granules during pigment aggregation 
by blocking the path of dynein motors.
In a marked contrast to pigment aggre-
gation, overexpression of XMAP4 does not 
inhibit  dispersion  of  pigment  granules, 
which requires the activity of kinesin-2 (Tuma 
et al., 1998). Thus, unlike dynein, kinesin-2 is 
capable  of  moving  along  MTs  bearing 
XMAP4.  The  lack  of  effect  on  kinesin-2–
driven transport might be explained by the 
particular isoform of XMAP4 expressing in 
Xenopus  melanophores.  Only  the  five-re-
peat isoform, and not the three- or four-re-
peat  isoforms,  of  mammalian  MAP4  sup-
presses gliding MTs driven by kinesin-1 in in 
vitro motility assays (Tokuraku et al., 2007), 
and it is possible that kinesin-2 shares with 
kinesin-1 insensitivity to the MAP4 isoforms 
with  reduced  numbers  of  MT-binding  re-
peats. Therefore specific isoforms of XMAP4 
might selectively affect motility of MT mo-
tors similar to yeast protein She1, which in-
hibits movement of dynein but not kinesins 
along MT tracks (Markus et al., 2012). How-
ever, it is also possible that movement along 
MTs with bound XMAP4 or other MAPs is an 
inherent property of kinesin-2, as the unique 
neck-linker region allows kinesin-2 to navi-
gate obstacles on the MT surface (Hoeprich 
et al., 2014). Unlike kinesin-1 or cytoplasmic 
dynein, which take straight paths, kinesin-2 
family  members  are  capable  of  switching 
protofilaments  (Brunnbauer  et  al.,  2012). 
The sideways steps may let kinesin-2 bypass 
molecules of XMAP4 and other MAPs ex-
tending from the MT wall (Hoeprich et al., 
2014).
We  unexpectedly  discovered  that 
XMAP4  positively  regulates  plus  end–di-
rected runs of pigment granules during pig-
ment dispersion. This conclusion is based 
on the results of experiments that involved 
microinjection of blocking antibodies that 
removed  XMAP4  from  MTs.  In  Xenopus 
melanophores,  plus-end  runs  of  pigment 
granules have been shown to be generated 
by kinesin-2 (Tuma et al., 1998). Therefore 
our data suggest that, similar to MAP7/ensconsin, which activates 
kinesin-1 (Sung et al., 2008; Metzger et al., 2012; Barlan et al., 
2013a), and doublecortin/doublecortin-like kinase, which facilitates 
transport of membrane vesicles driven by Kif1A (Liu et al., 2012), 
XMAP4  stimulates  kinesin-2  motility.  Doublecortin  increases  the 
length of MT runs of Kif1A cargoes by enhancing binding of the 
Kif1A motor domain to MTs (Liu et al., 2012). We hypothesize that 
XMAP4 might stimulate kinesin-2 motility by a similar mechanism. 
Our  pull-down  experiments  indicate  that,  unlike  doublecortin, 
which forms a complex with Kif1A, XMAP4 does not binds kinesin-2 
directly.  However,  we  instead  observe  an  interaction  between 
XMAP4  and  the  p150Glued  subunit  of  the  dynactin  complex,  an 
adaptor  to  MT  motor  proteins  on  the  granule  surface  (Deacon 
et al., 2003). Mammalian MAP4 also immunoprecipitates p150Glued 
interphase mammalian cells prevents clustering of the Golgi cister-
nae in the cell center, which requires dynein activity (Bulinski et al., 
1997). Similarly, MAP4 suppresses dynein-dependent sliding of as-
tral MTs at the cell cortex essential for positioning of the mitotic 
spindle  and  inhibits  gliding  of  MTs  powered  by  dynein  in  vitro 
(Samora et al., 2011). On the other hand, motility of single dynein 
molecules along MTs in vitro was relatively insensitive to decoration 
of MTs with fragments of tau, a MAP structurally similar to the MAP4 
(Dixit et al., 2008; Vershinin et al., 2008). However, in living cells, 
dynein motors moving pigment granules have to overcome signifi-
cant viscous drag and therefore might be more susceptible to ob-
stacles on the MT surface. Further, XMAP4 might be a more efficient 
inhibitor of dynein motility than MT-binding fragments of tau used in 
the in vitro motility assays. Therefore it is likely that XMAP4 inhibits 
FIGURE 6:  Phosphorylation of XMAP4 reduces inhibition of pigment aggregation and 
decreases binding to MTs. (A) Top, quantification of the response to a pigment aggregation 
stimulus of melanophores overexpressing nonphosphorylatable (left set of bars) or 
phosphomimetic (right set of bars) mutants or XMAP4; data are expressed as the percentages 
of cells with aggregated (white bars), partially responded (gray bars), or dispersed (black bars) 
pigment granules. Bottom, comparison of the levels of expression of XMAP4 mutants based on 
the EGFP fluorescence. Overexpression of the phosphomimetic XMAP4 mutant has a weaker 
inhibitory effect compared with the nonphosphorylatable mutant, as evidenced by a smaller 
fraction of cells with dispersed and larger fraction of cells with aggregated pigment granules 
compared with melanophores overexpressing the XMAP4 nonphosphorylatable mutant; this 
difference cannot be explained by the reduced expression levels of the phosphomimetic 
mutant, given that the mutants are expressed at approximately the same levels. 
(B) Cosedimentation of recombinant nonphosphorylatable and phosphomimetic XMAP4 mutant 
proteins with MTs in vitro. Top, Coomassie-stained gel, which shows protein composition of 
input (XMAP4 mutant protein–MT mixtures before centrifugation; I), supernatants (S), and MT 
pellets (P). Bottom, measurement of relative amounts of nonphosphorylatable (left) and 
phosphomimetic (right) mutant proteins in MT pellets using quantitative immunoblotting; the 
data represent averages for the values measured in three independent experiments; inset, 
representative images of the XMAP4 mutant bands. The amount of the phosphomimetic mutant 
protein in the MT pellets is significantly smaller, and in the supernatants larger, than the 
nonphosphorylatable mutant, which indicates reduced binding to MTs.3128  |  I. Semenova et al.  Molecular Biology of the Cell
vivo  and  in  vitro  (Ookata  et  al.,  1995;  Illenberger  et  al.,  1996; 
Drewes et al., 1997; Shiina and Tsukita, 1999; Kitazawa et al., 2000; 
Chang et al., 2001; Chinnakkannu et al., 2010). In mammalian cells, 
Thr-758 and Thr-762 are phosphorylated during transition to mito-
sis by p34cdc2 and mitogen-activated protein kinases, which induce 
dissociation  of  MAP4  from  MTs  (Ookata  et  al.,  1995;  Shiina 
and Tsukita, 1999). The identity of protein kinases that phosphory-
late XMAP4 in Xenopus melanophores is unknown, but it is clear 
that their activities must be stimulated by the decrease in cytoplas-
mic levels of cAMP and activity of PKA, which trigger aggregation 
of pigment granules (Daniolos et al., 1990; Rodionov et al., 2003). 
Our previous work indicates that PKA and other components of the 
signaling cascades that regulate MT motors are bound to the sur-
face of pigment granules (Kashina et al., 2004). We suggest that 
protein  kinases  that  phosphorylate  XMAP4  are  bound  together 
with PKA to the MT surface. Attachment of signaling enzymes to 
MTs might be mediated by the XMAP4 itself or other MAPs distrib-
uted along the MT length. In support of this idea, MAP4 and MAP2 
are  known  to  mediate  binding  of  p34cdc2  kinase  (Ookata  et  al., 
1995) and PKA (Obar et al., 1989) to MTs. Scaffolding of signaling 
enzymes by MAPs would bring protein kinases in proximity to their 
substrates and allow for the rapid release of MAP4 and other MAPs 
from  MTs,  clearing  a  path  for  dynein  motors  during  pigment 
aggregation.
On the basis of our results, we propose a hypothesis for the reg-
ulation  of  MT-based  transport  of  pigment  granules  by  XMAP4 
(Figure 7). We suggest that binding of XMAP4 to MTs creates ob-
stacles in the path of dynein motors and therefore negatively regu-
lates dynein-dependent motility of pigment granules. Conversely, 
attachment of XMAP4 to MTs positively regulates kinesin-2–based 
motility due to the interaction of XMAP4 with p150Glued bound to 
pigment granules, which increases the length of plus-end runs by 
keeping the kinesin-2 motor domain close to the MT surface. Phos-
phorylation of XMAP4 on Thr-758 and Thr-762 during aggregation 
reduces the binding of XMAP4 to MTs, thus increasing minus end–
directed  and  decreasing  plus  end–directed  motility  of  pigment 
granules, causing their accumulation in the cell center (Figure 7, 
left), whereas dephosphorylation of XMAP4 during pigment disper-
sion has the opposite effect (Figure 7, right).
from cell extracts, which indicates that the interaction between the 
two proteins is highly conserved (Samora et al., 2011). We hypoth-
esize that transient attachment of XMAP4 to p150Glued during gran-
ule movement may keep kinesin-2 in proximity to the MT wall, 
reducing the detachment rate and therefore increasing the length 
of uninterrupted runs of relatively nonprocessive kinesin-2 motors 
(Muthukrishnan et al., 2009).
Surprisingly, our data indicate that effects of XMAP4 on granule 
runs in each direction are different in the two signaling states. Over-
expression of XMAP4 does not increase the average length of plus-
end runs during pigment granule aggregation as would be expected 
in light of a positive effect of XMAP4 on plus-end run length during 
dispersion of pigment granules. Similarly, removal of XMAP4 from 
MTs during granule dispersion reduced the length of minus-end 
granule runs, which is apparently inconsistent with the minus-end 
run length decrease during granule aggregation in XMAP4-overex-
pressing cells. We hypothesize that the observed differences in ef-
fects of XMAP4 on granule runs during pigment aggregation and 
dispersion might be explained by variations in sensitivity to XMAP4 
by the active and inactive states of MT motors. In the fully active 
state typical for pigment aggregation, dynein might be highly sensi-
tive to XMAP4 obstacles on the MT surface. On the contrary, in an 
inactive state characteristic of pigment dispersion, dynein processiv-
ity  is  enhanced  by  XMAP4,  presumably  through  interaction  of 
XMAP4 with p150Glued on the granule surface. Similarly, XMAP4 en-
hances plus end–directed granule runs generated by active kine-
sin-2 motors during pigment dispersion, but binding of XMAP4 to 
MTs might be insufficient to activate kinesin-2 motility during ag-
gregation of pigment granules. It is therefore likely that reversible 
binding of XMAP4 to MTs cooperates with independent regulation 
of the activities of MT motors to control the direction of MT-based 
transport of pigment granules.
Our  data  show  that  during  pigment  aggregation,  XMAP4  is 
phosphorylated on Thr-758 and Thr-762 located in the proline-rich 
region of the MBD. This phosphorylation reduces the affinity of 
XMAP4 binding to MTs, as evidenced by the decreased cosedi-
mentation of the phosphomimetic mutant protein with MTs in vitro. 
These data are consistent with the result of studies that show that 
phosphorylation of MBD causes detachment of MAP4 from MTs in 
FIGURE 7:  Hypothesis for the regulation of MT-based transport of pigment granules by XMAP4. XMAP4 negatively 
regulates minus end–directed MT transport of pigment granules by blocking the movement of dynein motors along MTs 
and positively regulates plus end–directed, kinesin-2–based transport through interaction with the granule-bound 
p150Glued. This interaction increases processivity of kinesin-2 motors by keeping them in proximity to the MT surface. 
Phosphorylation during pigment aggregation reduces binding of XMAP4 to MTs, thus increasing minus end–directed 
and decreasing plus end–directed motility of pigment granules (left), which stimulates their accumulation at the cell 
center, whereas dephosphorylation of XMAP4 during pigment dispersion has an opposite effect (right).Volume 25  October 15, 2014  Regulation of transport by MAP4  |  3129 
DNA  amplification:  CCGGCTCGAGCATGGCGGACCTTGGAC 
(forward  primer)  and  CGCCCCGCGGTTAGATGCTTGTCTCTGG 
(reverse primer). The PCR product was cloned into pEGFP-C2 vec-
tor (Clontech, Mountain View, CA) using XhoI and SacII restriction 
sites  and  verified  by  sequencing.  Amino  acid  sequence  of  the 
cloned protein was identical to the sequence published for XMAP4 
except that it had a 10–amino acid insert (AEVLSAPIPE) between 
the amino acid residues 63 and 73 and a 57–amino acid deletion 
between the amino acid residues 1056–1112 in the C-terminal 
region of the molecule. Several independent amplification experi-
ments produced PCR products with the same nucleotide sequence, 
which indicated that the amplified DNA encoded the principal iso-
form of XMAP4 expressed in melanophores.
Phosphomimetic  (T758E/T762E)  and  nonphosphorylatable 
(T758A/T762A)  mutants  of  XMAP4  were  generated  using 
QuikChange XL Site-Directed Mutagenesis Kit (Agilent Technolo-
gies, Santa Clara, CA).
Expression of XMAP4 mutant proteins in baculovirus
Recombinant  phosphomimetic  and  nonphosphorylatable  XMAP4 
mutant proteins were expressed in baculovirus using the Bac-to-Bac 
Baculovirus expression system (Life Technologies). To facilitate puri-
fication of recombinant proteins and enable detection of protein 
expression, 6xHis and mCherry tags were added to the N-termini of 
the XMAP4 sequences. 6xHis/mCherry tag DNA was amplified by 
PCR using mCherry N1 mammalian expression vector (Clontech) as 
a template and cloned into pFastBac1 vector (Life Technologies) us-
ing BamH1 and EcoRI restriction sites. PCR-amplified XMAP4 mu-
tant DNAs were cloned into pFastBac1 vector downstream of the 
6xHis/mCherry tag using SpeI and XhoI restriction sites. Recombi-
nant bacmid and baculovirus stocks were produced according to 
instructions provided by the kit manufacturer. For protein expres-
sion, Sf9 cells were infected with baculovirus and incubated for 48 h 
in Sf-900 II medium (Life Technologies) containing 50 U/ml penicillin 
and 50 μg/ml streptomycin. Cells were pelleted at 1000 × g for 
10 min at 4°C and washed with PBS. Cell pellets were resuspended 
in the lysis buffer (20 mM Tris, 500 mM NaCl, 10 mM imidazole, 
1 mM MgCl2, 1% Triton X-100, 5 mM β-mercaptoethanol, 0.5 mM 
MgATP, 1 mM PMSF, pH 7.5) and incubated on ice for 45 min for the 
cell lysis. Cell lysates were clarified by centrifugation at 100,000 × g 
for 30 min at 4°C and used for purification of recombinant proteins 
by chromatography on Ni-NTA Agarose (Qiagen, Valencia, CA) ac-
cording to instructions provided by the manufacturer.
Cell transfection
Melanophores were transfected using GeneCellin DNA transfection 
reagent  (Bulldog  Bio,  Portsmouth,  NH)  according  to  instructions 
provided by the manufacturer. After transfection, cells were incu-
bated for 2–4 d at 27°C for protein expression.
Production of antibodies against XMAP4
For production of antibodies against the MBD of XMAP4, a frag-
ment of DNA that encoded amino acids 722–1228 of XMAP4 was 
amplified  by  PCR  using  GGAATTCCATATGGCA  GAACCT  GCT-
GCTGCAGC as forward primer and CCGCTCGAGTTA GATGCT-
TGT CTCTGG TATTAG as reverse primer. The PCR product was 
cloned into the bacterial expression vector pCold I DNA (Clontech) 
using the Nde and XhoI restriction sites. Recombinant protein was 
expressed in Escherichia coli according to instructions provided by 
the vector manufacturer, purified by affinity chromatography on Ni-
NTA agarose (Qiagen), dialyzed against PBS, and used for rabbit 
immunization. High-titer antisera were produced by Bio-Synthesis 
MATERIALS AND METHODS
Cell culture
Xenopus melanophores (Kashina et al., 2004) were cultured in Xe-
nopus tissue culture medium (70% L15 medium supplemented with 
0.2 mg/ml penicillin, 0.2 mg/ml streptomycin, 5 μg/ml insulin, and 
10% heat-inactivated fetal bovine serum) at 27°C. Before stimula-
tion of aggregation or dispersion, melanophores were transferred 
into serum-free 70% L15 medium and incubated for at least 1 h at 
27°C. Aggregation of pigment granules was induced by treatment 
with 10−8 M melatonin. For dispersion of pigment granules, cells 
were treated with 10−8 M melanocyte-stimulating hormone (MSH).
Quanatification of aggregation and dispersion responses 
of melanophores
To determine the fractions of cells with aggregated, partially re-
sponded, or dispersed pigment, melanophores were treated with 
melatonin or MSH for 15 min or 1 h and fixed with formaldehyde. 
The numbers of cells with aggregated, partially responded, or dis-
persed pigment granules were determined by counting cells in each 
category  by  phase-contrast  microscopy  as  described  previously 
(Kashina et al., 2004).
To determine kinetics of pigment aggregation, time series of 
bright-field images of melanophores treated with melatonin were 
acquired with 10-s time intervals. Integrated pixel values within cell 
outlines were determined for each of the acquired images using the 
region  measurement  tool  of  MetaMorph  image  acquisition  and 
analysis software (Molecular Devices, Downingtown, PA). The per-
centage of gray levels was calculated for each image as described 
previously (Lomakin et al., 2011). Data were averaged across the 
recorded cells and plotted as a function of time.
Mass spectrometry
Melanophores  grown  in  dense  monolayers  in  two  75-cm2  flasks 
were transferred into 70% serum-free L15 medium for 60 min, stimu-
lated with either melatonin or MSH for 60 min, washed twice with 
10 ml of ice-cold 0.7× phosphate-buffered saline (PBS), and lysed on 
ice by adding 1 ml of lysis buffer containing 8 M urea, 75 mM NaCl, 
50 mM Tris, pH 8.2, one tablet of protease inhibitor cocktail (Roche 
Applied Sciences, Indianapolis, IN) per 10 ml of lysis buffer, 1 mM 
NaF,  1  mM  β-glycerophosphate,  1  mM  sodium  orthovanadate, 
10 mM sodium pyrophosphate, and 1 mM phenylmethylsulfonyl 
fluoride (PMSF). Cell lysates were sonicated and clarified by centrifu-
gation.  Proteins  were  reduced  and  alkylated  and  digested  with 
trypsin as described previously (Villen and Gygi, 2008). After desalt-
ing and strong cation exchange (SCX) chromatography, phospho-
peptides were selectively enriched by a combination of SCX chro-
matography and immobilized metal affinity chromatography (Villen 
and Gygi, 2008). Liquid chromatography–tandem mass spectrome-
try (MS/MS) was performed on an LTQ Orbitrap hybrid mass spec-
trometer  (Thermo  Fisher,  San  Jose,  CA).  MS/MS  spectra  were 
searched via the SEQEST algorithm with the target-decoy strategy 
(Elias and Gygi, 2007) against a Xenopus laevis open reading frame 
database. Ascore algorithm (Beausoleil et al., 2006) was used to as-
sign phosphorylation site localization.
XMAP4 cloning and mutagenesis
DNA for the XMAP4 from Xenopus melanophores was amplified 
by PCR using as a template cDNA synthesized with SuperScriptII 
reverse transcriptase (Life Technologies, Carlsbad, CA) from the 
total melanophore RNA. The following set of primers designed 
against the X. laevis XMAP4 (National Center for Biotechnology 
Information accession number NP_001083770.1) was used for the 3130  |  I. Semenova et al.  Molecular Biology of the Cell
incubated with mouse monoclonal antibodies against α-tubulin 
(1:200, DM1A; Cedarlane Laboratories, Burlington, NC) and goat 
anti-mouse antibodies conjugated with Alexa Fluor 488 (1:200; 
Invitrogen). Immunofluorescence staining of MTs was followed by 
the incubation cells with goat anti-rabbit antibodies conjugated 
with rhodamine (1:200; KPL, Gaithersburg, MD), which allowed us 
to identify the microinjected cells. For immunofluorescence stain-
ing of CLIP170 comets, melanophores were fixed in cold metha-
nol, postfixed with 4% formaldehyde, permeabilized with 0.1% 
Triton X-100, and immunostained with antibodies specific for CLIP-
170 N-terminus (no. 2221; 1:200; Hoogenraad et al., 2000) and 
goat  anti-rabbit  antibodies  conjugated  with  Alexa  488  (1:200; 
Invitrogen).
For double immunofluorescence staining with XMAP4 MBD 
and tubulin antibodies, melanophores treated for 5 min with me-
latonin or 3 min with MSH were briefly rinsed with PBS and placed 
for 2 min in permeabilization buffer containing 60 mM 1,4-pip-
erazinediethanesulfonic acid, 25 mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid, 10 mM ethylene glycol tetraacetic acid, 
2 mM MgCl2, 20 mM paclitaxel, and 0.5% Triton X-100. After 
permeabilization, cells were washed with PBS, fixed with 1% glu-
taraldehyde for 30 min, treated with NaBH4 to quench the unre-
acted glutaraldehyde, and blocked with 2% solution of bovine 
serum albumin. Cells were then sequentially incubated with affin-
ity-purified  antibodies  against  XMAP4  MBD  (0.7  μg/ml),  goat 
anti-rabbit antibodies conjugated with rhodamine (1:200; KPL), 
mouse monoclonal antibodies against α-tubulin (1:200, DM1A; 
Cedarlane Laboratories), and goat-anti-mouse antibodies conju-
gated with Alexa Fluor 488 (1:200, Invitrogen). Immunostained 
cells were mounted in Aqua-Poly/Mount medium (Polysciences, 
Warrington, PA).
Image acquisition and analysis
Fluorescence images of melanophores were acquired using a Nikon 
Eclipse Ti inverted microscope equipped with a Plan Apochromat 
100×/1.4 numerical aperture objective lens and Andor iXon EM-
CCD sensor (Andor Technology, Windsor, CT) driven by MetaMorph 
image acquisition and analysis software (Molecular Devices, Down-
ingtown, PA). MT dynamics was measured by acquiring time series 
of images of Cy3-labeled MTs, as described previously (Semenova 
and Rodionov, 2007). To reduce photobleaching and photodam-
age, cells were treated with the oxygen-depleting agent Oxyrase 
(Oxyrase Company, Mansfield, OH) before image acquisition. Tips 
of individual MTs were manually tracked using MetaMorph soft-
ware. Parameters of MT dynamic instability were determined by 
decomposing the trajectories of MT ends into phases of growth, 
shortening, and pauses using multiscale trend analysis (Lomakin 
et al., 2009). The length of CLIP-170 comets and the amount of 
CLIP-170 bound to MT ends were measured as described previ-
ously (Lomakin et al., 2011). For quantification of expression levels 
of XMAP4 mutants, images of 100 cells expressing GFP-tagged 
phosphomimetic or nonphosphorylatable mutant were acquire us-
ing a fluorescein filter set, and the values for average gray levels 
within the cell outlines were determined using the Region Measure-
ments Tool of MetaMorph software. For quantification of levels of 
XMAP4 bound to MTs, images of 20 cells stimulated with either 
melatonin or MSH immunostained with XMAP4 MBD antibodies 
and  rhodamine-conjugated  secondary  antibodies  were  acquired 
using a rhodamine filter set, and the MetaMorph Region Measure-
ments Tool was used to quantify average fluorescence over five 
∼1-μm MT segments in each cell. After background subtraction, the 
results of fluorescence measurements were averaged separately for 
(Lewisville, TX). Polyclonal antibodies were purified from antisera by 
affinity chromatography on a CNBr-activated Sepharose 4B (Sigma-
Aldrich, St. Louis, MO) with covalently attached antigen. Purified 
antibodies were dialyzed against microinjection buffer and concen-
trated by ultrafiltration.
Polyclonal antibodies against XMAP4 projection domain were 
generated by immunization of rabbits with the synthetic peptide 
GCDDDDVKEPKNKSERSAAPHD  manufactured  by  Bio-Synthesis, 
which corresponded to the amino acid residues 56–75 of XMAP4. 
Antibodies were purified by affinity chromatography of antisera on 
SulfoLink resin (Thermo Scientific, Rockford, IL) with covalently at-
tached peptide antigen.
Cosedimentation of recombinant XMAP4 mutant proteins 
with MTs
MTs were assembled by polymerization of purified porcine brain 
tubulin  (Cytoskeleton,  Denver,  CO)  in  the  presence  of  paclitaxel 
(20 μM; Sigma-Aldrich), and recombinant XMAP4 mutant proteins 
were added at 1:1 molar ratio to tubulin. After incubation for 30 min 
at room temperature, MTs were pelleted by centrifugation through 
a glycerol cushion at 140,000 × g for 40 min at 25°C, and the MT 
pellets were resuspended in SDS–PAGE sample buffer. The amounts 
of XMAP4 mutant proteins in the MT pellets were measured by 
quantitative immunoblotting.
Immunoprecipitation and immunoblotting
For immunoprecipitation, whole-cell extracts were incubated for 2 h 
at room temperature with rabbit affinity-purified anti-GFP antibod-
ies (ab290; Abcam, Cambridge, MA) or antibodies against XMAP4 
MBD  bound  to  protein  A  agarose  (Thermo  Scientific).  Agarose 
beads  were  pelleted  and  washed,  and  adsorbed  proteins  were 
eluted by the treatment of beads with SDS–PAGE sample buffer for 
5 min at 100°C.
Immunoblotting  was  performed  by  the  method  described  in 
Towbin et al. (1979). Blots were stained with mouse monoclonal GFP 
antibodies (ab1218; Abcam), p150Glued subunit of the dynactin com-
plex (610473; BD Biosciences, San Jose, CA), cytoplasmic dynein IC 
(74.1; Covance, Princeton, NJ), or kinesin-2 motor subunit (K2.4; 
Covance). Immunoreactive bands were detected with SuperSignal 
West  Femto  maximum-sensitivity  substrate  (Thermo  Scientific, 
Waltham, MA). To measure the amounts of recombinant XMAP4, 
nonphosphorylatable and phosphomimetic mutant proteins cosedi-
mented with MTs, blots of MT pellets were successively incubated 
with  antibodies  against  XMAP4  MBD  and  IRDye800-conjugated 
affinity-purified  anti-mouse  IgG  (Rockland  Immunochemicals, 
Gilbertsville, PA), and the intensity of the infrared signal was quanti-
fied with the Odyssey Infrared Imaging System (Li-Cor Biosciences, 
Lincoln, NE).
Microinjection
Pressure  microinjection  of  antibodies  against  XMAP4  MBD 
(8–10 mg/ml), nonimmune rabbit IgG (12 mg/ml), and Cy3-labeled 
porcine brain tubulin (6–7 mg/ml) was performed using the PLI-100 
Pico-Liter microinjection system (Harvard Apparatus, Hollistson, MA) 
as  described  previously  (Semenova  and  Rodionov,  2007;  Ikeda 
et al., 2010).
Immunofluorescence staining
For immunofluorescence staining of MTs, melanophores microin-
jected with antibody against XMAP4 MBD were briefly rinsed with 
PBS, fixed with glutaraldehyde, permeabilized with PBS contain-
ing 1% Triton X-100 (Ted Pella, Redding, CA), and sequentially Volume 25  October 15, 2014  Regulation of transport by MAP4  |  3131 
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